David S. Ivill provides representation on regulatory and related transactional issues for a wide array of health industry clients, including for-profit and nonprofit hospitals, covered entities involved in the 340B Federal Drug Pricing Program, private equity firms, post-acute providers, large medical group providers and specialty pharmacies. He provides operational and management advice in the context of complex regulatory frameworks, whether it be for the course of business or in connection with affiliations or mergers and acquisitions. He has extensive experience in statutory and regulatory issues affecting the provision of health care services, particularly with respect to New York State. David is the partner-in-charge of the Health Industry Advisory Practice in New York.
Prior to practicing law, David was a podiatric surgeon specializing in foot and ankle reconstruction with a subspecialty in osteomyelitis of the lower extremity. He completed his residency at St. Joseph's Hospital in Philadelphia and an AO Fellowship (for reconstructive surgery and surgical intervention for infections) in Ravensburg, Germany.
David frequently speaks on topics of interest to health care providers and manufacturers, including the following issues:
While in law school, David served as an articles editor for the Review of Law & Social Change.